Nippon India Mutual Fund has declared Income Distribution cum Capital Withdrawal (IDCW) for 38 schemes under its portfolio, with March 20, 2026 set as the record date. The announcement covers a comprehensive range of debt and hybrid fund schemes with varying distribution amounts and frequency options.

Distribution Details Across Fund Categories

The distribution amounts vary significantly across different schemes and plan types. The highest distribution of ₹16.4681 per unit has been declared for Nippon India Ultra Short Duration Fund - Direct Plan - Quarterly IDCW Plan, while the lowest distribution of ₹0.0151 per unit applies to Nippon India Nivesh Lakshya Long Duration Fund - Quarterly IDCW Plan.

Duration Fund Performance

The Medium to Long Duration Fund category shows varied distribution patterns across different payout frequencies. The Direct Plan variants consistently offer higher distribution amounts compared to regular plans within the same category.

Liquid and Money Market Funds

The liquid fund and money market fund categories demonstrate substantial distribution amounts, reflecting their higher face values. Nippon India Liquid Fund schemes show distributions ranging from ₹14.8292 to ₹16.0479 per unit, with NAV values exceeding ₹1000 per unit.

Key Terms and Conditions

The IDCW distribution will be processed net of tax deducted at source, as applicable. Following the dividend payout, the NAV of all schemes will decrease by the extent of the distribution amount plus any statutory levy. The actual payout will be limited to the mentioned distribution amount or available distributable surplus as on the record date, whichever is lower.

For units held in demat form, IDCW will be paid to unitholders whose names appear in the beneficial owners' statement maintained by depositories. All unitholders under the IDCW plan whose names appear on the register as of the record date will be entitled to receive the distribution.

Fund Structure Details

The face value for most schemes is ₹10 per unit, with specific exceptions including Nippon India Low Duration Fund, Liquid Fund, Ultra Short Duration Fund, and Money Market Fund having a face value of ₹1000 per unit. Nippon India Overnight Fund maintains a face value of ₹100 per unit. The announcement was made by Nippon Life India Asset Management Limited on March 16, 2026, serving as the Asset Management Company for Nippon India Mutual Fund.

Artemis Medicare Services delivered robust financial performance in Q3 FY26, demonstrating strong growth across key operational metrics while announcing ambitious expansion plans that will significantly scale its healthcare infrastructure over the next few years.

Financial Performance Highlights

The company's financial results for Q3 FY26 showed consistent growth momentum across all major parameters:

For the nine-month period ending December 2025, the company reported consolidated revenues of INR 802 crores, representing a 15.1% year-on-year increase. EBITDA for nine months FY26 reached INR 159 crores with a margin of 19.8%, while net profit stood at INR 73 crores compared to INR 59 crores in the corresponding period of FY25.

Operational Excellence and Key Metrics

Artemis Medicare's flagship facility in Gurugram maintained strong operational performance with several key indicators showing positive trends:

The company's international patient revenue demonstrated exceptional growth of 34.9%, contributing INR 89 crores to total revenues. This growth reflects Artemis Medicare's strong position in medical tourism, serving patients from 52 countries across the Middle East, Africa, and CIS regions.

Major Expansion Plans and Fundraising

Artemis Medicare announced a comprehensive expansion strategy that will transform its scale and reach. The company's board has approved a INR 700 crore fundraise through a combination of Qualified Institutional Placement (QIP) and preferential allotment to fund this ambitious growth plan.

Current and Planned Facilities

The Raipur facility represents a capex investment of INR 100 crores for 300 beds, structured as a long-term lease arrangement. The facility will begin operations with 200 beds, scaling to full capacity within 18 months, with expected ARPOB of INR 30,000 to INR 35,000 initially.

Strategic Infrastructure Developments

The company achieved significant milestones in infrastructure enhancement during the quarter. Artemis Medicare received platinum green building certification, which entitles the company to a 15% increase in Floor Area Ratio (FAR). This certification allows the addition of 100 to 125 more beds to the Gurugram facility at no additional land cost.

The South Delhi facility, planned as a 650-bed super specialty hospital, will be developed on trust land with an estimated cost of INR 75 to INR 80 lakhs per bed. This compares favorably to typical South Delhi healthcare facility costs of INR 1.75 to INR 2 crores per bed.

Technology and Service Expansion

Artemis Medicare continued investing in advanced medical capabilities and digital transformation initiatives. The company implemented AI-assisted triage systems across facilities to enhance patient experience and operational efficiency. New service lines launched during the quarter include:

• Heart-lung transplant programs
• Advanced robotic surgery capabilities
• Comprehensive geriatrics packages
• Enhanced oncology and organ transplant services

These high-value service additions, while requiring initial manpower investments, are expected to generate significant returns with procedures ranging from INR 35 to INR 55 lakhs for heart-lung transplants and INR 5 to INR 7 lakhs for annual geriatric packages.

Financial Strategy and Debt Management

The planned fundraising will enable the company to maintain conservative debt levels while funding aggressive expansion. Management indicated that maximum debt levels will remain below INR 300 crores, specifically in the INR 250 to INR 280 crore range, even with the substantial expansion program.

The fundraising structure ensures promoter majority retention, with current promoter shareholding at 58.3% post-CCD conversion, and commitment to maintain above 50% ownership even after the new fundraise.